Cargando…

Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries

Background: Polymyalgia rheumatica (PMR) is the most common systemic inflammatory rheumatic disease affecting the elderly. Giant cell arteritis (GCA) is a granulomatous vasculitis affecting the aorta and its branches associated with PMR in up to 20% of cases. In recent studies based on university ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzo, Ciro, Milchert, Marcin, Venditti, Carlo, Castagna, Alberto, Nune, Arvind, Natale, Maria, Brzosko, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317449/ https://www.ncbi.nlm.nih.gov/pubmed/35888074 http://dx.doi.org/10.3390/life12070985

Ejemplares similares

Polymyalgia Rheumatica (PMR) with Normal Values of Both Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentration at the Time of Diagnosis in a Centenarian Man: A Case Report
por: Manzo, Ciro
Publicado: (2018)

Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
por: Manzo, Ciro, et al.
Publicado: (2020)

Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?
por: Manzo, Ciro, et al.
Publicado: (2022)

Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis: a four-point guidance
por: Manzo, Ciro, et al.
Publicado: (2018)

Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case
por: Manzo, Ciro
Publicado: (2019)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023)

Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder
por: Manzo, Ciro, et al.
Publicado: (2023)

Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
por: Milchert, Marcin, et al.
Publicado: (2020)

Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center Study
por: Manzo, Ciro, et al.
Publicado: (2023)

Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient
por: Milchert, Marcin, et al.
Publicado: (2017)

Polymyalgia Rheumatica (PMR) and Lung Involvement: The Forgotten Association
por: Hammoda, Hoda Mohamed Bakri, et al.
Publicado: (2020)

Relapse of polymyalgia rheumatica after a fall
por: Manzo, Ciro, et al.
Publicado: (2017)

Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Hysa, Elvis, et al.
Publicado: (2020)

The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios
por: Manzo, Ciro, et al.
Publicado: (2022)

Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
por: Manzo, Ciro, et al.
Publicado: (2021)

Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
por: Manzo, Ciro, et al.
Publicado: (2016)

The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study
por: Tshimologo, Maatla, et al.
Publicado: (2018)

Messages from the history of polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2021)

Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021)

Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literature
por: Manzo, Ciro, et al.
Publicado: (2021)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021)

Normal ESR, CRP and Platelet Count in Giant Cell Arteritis and Polymyalgia Rheumatica: A Diagnostic Conundrum
por: Mahgoub, Abdullahi Elsheikh, et al.
Publicado: (2022)

Polymyalgia Rheumatica (PMR) Lacking Shoulder Pain Following COVID-19 Vaccination
por: Haruna, Kotaro, et al.
Publicado: (2023)

Polymyalgia Rheumatica in Association with Remitting Seronegative Sinovitis with Pitting Edema: a Neoplastic Warning
por: Manzo, Ciro, et al.
Publicado: (2017)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
por: Manzo, Ciro, et al.
Publicado: (2022)

Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2022)

The impact of polymyalgia rheumatica on intimate sexual relationships: findings from the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2022)

Diagnosis of polymyalgia rheumatica in primary health care: favoring and confounding factors – a cohort study
por: Manzo, Ciro, et al.
Publicado: (2018)

Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2016)

Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
por: Manzo, Ciro, et al.
Publicado: (2020)

Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature
por: Hysa, Elvis, et al.
Publicado: (2021)

Patients' views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR Cohort Study
por: Tshimologo, Maatla, et al.
Publicado: (2017)

Longitudinal clusters of pain and stiffness in polymyalgia rheumatica: 2-year results from the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2020)

Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study
por: Sokhal, Balamrit Singh, et al.
Publicado: (2021)

Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial
por: Ma, Xinlei, et al.
Publicado: (2023)

Not just pain and morning stiffness duration in the daily experience of patients with polymyalgia rheumatica. Does the rheumatologist listen to all patient-reported outcomes?
por: Manzo, Ciro, et al.
Publicado: (2021)

Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2pr6kdt8l0pe5bjhrkuirbkiqc